Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACORNASDAQ:OTRKNASDAQ:RMTIOTCMKTS:WOWU On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACORAcorda Therapeutics$9.68$0.61▼$24.20$820K1.4119,299 shs416,900 shsOTRKOntrak$1.70+3.7%$1.50$1.27▼$5.53$7.17M2.3453,039 shs35,993 shsRMTIRockwell Medical$1.04-7.1%$1.22$0.86▼$5.15$35.54M1.64420,553 shs773,737 shsWOWUWOWI$0.03$0.03$0.01▼$0.20$900K-28.21N/AN/ABeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACORAcorda Therapeutics0.00%0.00%0.00%0.00%0.00%OTRKOntrak+3.66%+9.68%+8.31%+11.84%-58.62%RMTIRockwell Medical-6.73%-12.61%-1.89%-41.90%-36.59%WOWUWOWI0.00%0.00%0.00%0.00%+28.44%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACORAcorda TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AOTRKOntrak3.3094 of 5 stars3.55.00.00.03.80.01.3RMTIRockwell Medical4.1714 of 5 stars3.75.00.04.11.61.70.0WOWUWOWIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACORAcorda Therapeutics 0.00N/AN/AN/AOTRKOntrak 3.00Buy$45.002,547.06% UpsideRMTIRockwell Medical 3.33Buy$4.00284.62% UpsideWOWUWOWI 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest WOWU, OTRK, ACOR, and RMTI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/24/2025RMTIRockwell MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$7.00 ➝ $3.00(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACORAcorda Therapeutics$117.63M0.00N/A0.02($127.17) per share0.00OTRKOntrak$10.85M0.66N/AN/A$5.56 per share0.31RMTIRockwell Medical$101.49M0.35$0.01 per share92.73$0.75 per share1.39WOWUWOWIN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACORAcorda Therapeutics-$252.85M-$203.83N/AN/AN/A-214.95%-2,206.93%-83.28%N/AOTRKOntrak-$27.92M-$15.81N/AN/AN/A-237.77%-171.34%-113.42%N/ARMTIRockwell Medical-$8.44M-$0.02N/AN/AN/A-1.25%8.55%3.80%N/AWOWUWOWIN/AN/A0.00∞N/AN/AN/AN/AN/ALatest WOWU, OTRK, ACOR, and RMTI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025RMTIRockwell Medical-$0.03-$0.04-$0.01-$0.04$17.46 million$18.91 million4/14/2025Q4 2024OTRKOntrak-$1.35-$9.54-$8.19-$9.54$3.08 million$3.08 million3/20/2025Q4 2024RMTIRockwell Medical$0.02-$0.02-$0.04-$0.02$23.65 million$24.67 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACORAcorda TherapeuticsN/AN/AN/AN/AN/AOTRKOntrakN/AN/AN/AN/AN/ARMTIRockwell MedicalN/AN/AN/AN/AN/AWOWUWOWIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACORAcorda Therapeutics3.070.330.26OTRKOntrak0.191.171.17RMTIRockwell Medical0.332.412.00WOWUWOWIN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACORAcorda Therapeutics12.71%OTRKOntrak12.95%RMTIRockwell Medical23.31%WOWUWOWIN/AInsider OwnershipCompanyInsider OwnershipACORAcorda Therapeutics2.60%OTRKOntrak1.90%RMTIRockwell Medical3.60%WOWUWOWI41.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACORAcorda Therapeutics1111.24 million1.21 millionNo DataOTRKOntrak2504.22 million4.14 millionNo DataRMTIRockwell Medical30034.18 million31.71 millionOptionableWOWUWOWI333.21 million19.95 millionNot OptionableWOWU, OTRK, ACOR, and RMTI HeadlinesRecent News About These CompaniesWorld Of Warcraft's Trading Post Gives Players Free Cash And A Great SaleFebruary 1, 2023 | msn.comWorld of Warcraft gets a battle pass today with the Trading Post — fancy cosmetics and a few bugs aboundFebruary 1, 2023 | vg247.comWorld of Warcraft: All The Warlock Demons And When To Use ThemFebruary 1, 2023 | gamerant.comSteph Connects: Attending a Bear Moon Pow Wow and connecting with the Native communityFebruary 1, 2023 | tmj4.comThe WoW trading post release date is finally here, but it’s brokenFebruary 1, 2023 | pcgamesn.comNew WoW: Dragonflight Reward Takes 1 Year of Grinding to UnlockFebruary 1, 2023 | msn.comWorld of Warcraft Trading Post explained — how to earn tender tokens and complete challengesFebruary 1, 2023 | vg247.comOne of Ulduar’s toughest bosses hit with nerfs in WoW Wrath of the Lich King’s latest hotfixFebruary 1, 2023 | dotesports.comWoW players agree just one aspect of Shadowlands is better than DragonflightFebruary 1, 2023 | dotesports.comWorld of Warcraft's Trading Post is live now and will give you enough free cash to buy most of the stockFebruary 1, 2023 | pcgamer.comHow Camp Bow Wow in Eden Prairie protects pets during cold snapsFebruary 1, 2023 | msn.comWoW: Dragonflight Players Aren't Happy About One-Year Grind Required For New RewardJanuary 31, 2023 | gamespot.comWorld of Warcraft’s Story Needs to Revisit Older Zones More OftenJanuary 31, 2023 | msn.comHow to claim WoW Dragonflight Twitch drop: Goblin Weather MachineJanuary 31, 2023 | dexerto.comThe Best Battlegrounds In WoWJanuary 31, 2023 | msn.comWoW Patch 10.0.7 DetailsJanuary 31, 2023 | ign.comWoW Dragonflight’s most beloved quest once looked very differentJanuary 31, 2023 | pcgamesn.comWoW Dragonflight Patch 10.0.5 hotfix: Vault of the Incarnates bosses smashed with nerf hammerJanuary 31, 2023 | dotesports.com5 flooring trends to give your home the wow factorJanuary 31, 2023 | news.yahoo.comWarcraft 3: 10 Tips & Tricks For BeginnersJanuary 31, 2023 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeWOWU, OTRK, ACOR, and RMTI Company DescriptionsAcorda Therapeutics NASDAQ:ACORAcorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in adults with multiple sclerosis; and Inbrija, an inhaled levodopa for intermittent treatment of OFF periods in people with Parkinson's disease treated with a carbidopa/levodopa regimen. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. The company's product pipeline includes Cimaglermin alfa (GGF2), a member of neuregulin growth factor family which is in Phase 1 clinical trials for recovery of neurological injury, as well as to enhance heart function in animal models of heart failure. In addition, it has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. The company was incorporated in 1995 and is headquartered in Pearl River, New York.Ontrak NASDAQ:OTRK$1.70 +0.06 (+3.66%) Closing price 05/12/2025 04:00 PM EasternExtended Trading$1.60 -0.10 (-5.65%) As of 05/12/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.Rockwell Medical NASDAQ:RMTI$1.04 -0.08 (-7.14%) Closing price 05/12/2025 04:00 PM EasternExtended Trading$1.08 +0.03 (+3.37%) As of 04:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.WOWI OTCMKTS:WOWU$0.03 0.00 (0.00%) As of 05/9/2025WOWI, Inc., an early-stage company, engages in the business of licensing technology and intellectual property to operators and businesses in the legal cannabis industry in the United States. The company also provides packaging and labeling, as well as equipment and real property leasing services to various companies. In addition, it offers a plethora of consulting services, including proper business structure and management services in the legal cannabis space serving cultivations, growers, extractors, and dispensaries that operate legally in states that has legal medicinal and/or recreational legislation. The company is headquartered in Centennial, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs 5 Reasons the Rebound in Microchip Technology Stock Is Real Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
